Abstract:There have been more than 2.2 million confirmed cases and over 120 000 deaths from the human coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), in the United States alone. However, there is currently a lack of proven effective medications against COVID-19. Drug repurposing offers a promising route for the development of prevention and treatment strategies for COVID-19. This study reports an integrative, network-based deep-learning methodology to identify repurposable drugs for COVID-19 (termed CoV-KGE). Specifically, we built a comprehensive knowledge graph that includes 15 million edges across 39 types of relationships connecting drugs, diseases, proteins/genes, pathways, and expression from a large scientific corpus of 24 million PubMed publications. Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials. Whereas this study by no means recommends specific drugs, it demonstrates a powerful deep-learning methodology to prioritize existing drugs for further investigation, which holds the potential to accelerate therapeutic development for COVID-19.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jproteome.0c00316?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00316</a>.Supplementary Figure 1. Diagram illustrating the prioritization of drugs based on their distance to COVID-19 in the treatment relation space. Supplementary Table 1. Details of the five categories of relationships in our KG. Supplementary Table 2. Statistics of nodes (entity) and edges (relation) in our KG (<a class="ext-link" href="/doi/suppl/10.1021/acs.jproteome.0c00316/suppl_file/pr0c00316_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Drug Repositioning for SARS-CoV-2 Based on Graph Neural Network.

Dr-COVID: Graph Neural Networks for SARS-CoV-2 Drug Repurposing

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism

A network representation approach for COVID-19 drug recommendation

Self-Supervised Learning with Heterogeneous Graph Neural Network for COVID-19 Drug Recommendation.

Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence

Recent computational drug repositioning strategies against SARS-CoV-2.

Repositioning of 8565 existing drugs for COVID-19

Identification of targets for drug repurposing to treat COVID-19 using a Deep Learning Neural Network

Graph Neural Networks for COVID-19 Drug Discovery

SANE: A Sequence Combined Attentive Network Embedding Model for COVID-19 Drug Repositioning.

Drug repurposing prediction for COVID-19 using probabilistic networks and crowdsourced curation

Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning

Deep Learning Driven Drug Discovery: Tackling Severe Acute Respiratory Syndrome Coronavirus 2

Heterogeneous network-based drug repurposing for COVID-19

Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs

Predicting drug-Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Deep learning for drug repurposing: Methods, databases, and applications

A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2

Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding